185 reports of this reaction
2.2% of all SAPROPTERIN DIHYDROCHLORIDE reports
#10 most reported adverse reaction
ANXIETY is the #10 most commonly reported adverse reaction for SAPROPTERIN DIHYDROCHLORIDE, manufactured by BioMarin Pharmaceutical Inc.. There are 185 FDA adverse event reports linking SAPROPTERIN DIHYDROCHLORIDE to ANXIETY. This represents approximately 2.2% of all 8,360 adverse event reports for this drug.
Patients taking SAPROPTERIN DIHYDROCHLORIDE who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANXIETY is a less commonly reported adverse event for SAPROPTERIN DIHYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to anxiety, the following adverse reactions have been reported for SAPROPTERIN DIHYDROCHLORIDE:
The following drugs have also been linked to anxiety in FDA adverse event reports:
ANXIETY has been reported as an adverse event in 185 FDA reports for SAPROPTERIN DIHYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANXIETY accounts for approximately 2.2% of all adverse event reports for SAPROPTERIN DIHYDROCHLORIDE, making it a notable side effect.
If you experience anxiety while taking SAPROPTERIN DIHYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.